Lacka K, Kordel M, Gembicki M
Pol Tyg Lek. 1989;44(7-8):179-81.
The study aimed at: 1) assessing occurrence of HLA-A, HLA-B and HLA-C antigens in patients with Graves' disease in comparison with control group of healthy individuals; 2) determining relationship between circulating serum antimicrosomal and antithyroglobulin antibodies and selected HLA complex antigens. Human leukocyte antigens A, B, and C were detected with serological technique using cytotoxicity test. Thyroidal antimicrosomal and antithyroglobulin antibodies were titrated with radioimmunological solid phase technique while anti-membrane antibodies with immunoenzyme technique. The study involved 50 patients with Graves' disease and 50 healthy individuals. HLA-B8, HLA-B15, HLA-B35, and HLA-Cw3 antibodies were detected more frequently in patients with Graves' disease than in the healthy individuals. Antimicrosomal and antithyroglobulin antibodies were detected in the same group in 76% and 58% of patients, respectively whereas anti-membrane antibodies in 92% of patients. Comparison of the occurrence of thyroidal antimicrosomal and antithyroglobulin antibodies with the presence of HLA-B8, HLA-B35, HLA-B15, and HLA-Cw3 antigens did not show statistically significant correlation between these two parameters.
1)与健康个体对照组相比,评估格雷夫斯病患者中HLA - A、HLA - B和HLA - C抗原的出现情况;2)确定循环血清抗微粒体抗体和抗甲状腺球蛋白抗体与选定的HLA复合抗原之间的关系。使用细胞毒性试验的血清学技术检测人类白细胞抗原A、B和C。用放射免疫固相技术滴定甲状腺抗微粒体和抗甲状腺球蛋白抗体,而用免疫酶技术滴定抗膜抗体。该研究纳入了50例格雷夫斯病患者和50名健康个体。格雷夫斯病患者中HLA - B8、HLA - B15、HLA - B35和HLA - Cw3抗体的检测频率高于健康个体。同一组中分别有76%和58%的患者检测到抗微粒体和抗甲状腺球蛋白抗体,而92%的患者检测到抗膜抗体。甲状腺抗微粒体和抗甲状腺球蛋白抗体的出现情况与HLA - B8、HLA - B35、HLA - B15和HLA - Cw3抗原的存在情况比较,这两个参数之间未显示出统计学上的显著相关性。